Try our beta test site

Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Anaeropharma Science, Inc.
Sponsor:
Information provided by (Responsible Party):
Anaeropharma Science, Inc.
ClinicalTrials.gov Identifier:
NCT01562626
First received: March 22, 2012
Last updated: February 16, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)